- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07141888
- Original Trial
The Effects of a Probiotic Food Supplement in Hyperuricaemia (Bugs4U-PoC)
The Effects of a Novel Probiotic Food Supplement in Hyperuricaemia - Towards Development of an Individualised Treatment Strategy
The overall aim of the project is to determine whether a daily intake of health-promoting bacteria, known as probiotics, with or without a dietary fiber, affects uric acid levels in individuals with elevated levels of uric acid in the blood (hyperuricemia). Additionally, the project will investigate which individuals benefit from this dietary supplement and which do not, based on factors such as gut microbiota composition and function, dietary habits, genetic factors, and inflammatory status. The ultimate goal is to develop a personalized therapy for hyperuricemia.
At the beginning of the study, blood samples will be taken to determine uric acid levels and 99 individuals with hyperuricemia will be invited to participate in a 6-week intervention study with daily intake of dietary supplements. To examine the effect of the supplement on various health variables, blood, urine, stool, and breath samples will be collected on several occasions.
To better understand the underlying factors of hyperuricemia, questionnaire data and results from biological will be compared between participants with normal versus elevated uric acid levels. Furthermore, different outcome parameters from questionnaires and samples before and after supplement intake will be compared. In addition, various methods for estimating dietary intake will be investigated and compared with each other.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Örebro, Sweden
- Recruiting
- Örebro University
-
Contact:
- Julia König
- Email: b4u@oru.se
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Signed informed consent prior to any study-related procedures
- Age 18-80 years old
- BMI range 17.5-40 kg/m2
- Blood uric acid above 405 μmol/l (6.8 mg/dl)
- Willing to abstain from regular consumption of probiotic supplements or food products containing probiotic bacteria (including fermented food and beverages) during the study
- Willing to abstain from regular consumption of supplements and medications known to alter gastrointestinal function or inflammatory status during the study
Exclusion Criteria:
- Recent (within last month) episode of gout
- Diagnosis of type 1 diabetes
- Diagnosed inflammatory bowel disease (IBD)
- Current diagnosis of psychiatric disease/s or syndromes
- Current diagnosis of neurodegenerative disease
- Current pregnancy or breastfeeding
- History of complicated gastrointestinal surgery
- (Partial) resection of the small intestine or colon
- Regular use of urate-lowering treatment (apart from allopurinol) in the month prior to inclusion
- Oral or intravenous administration of antibiotics and/or corticosteroids in the 4 months prior to inclusion
- Regular use of any non-steroidal anti-inflammatory drug (NSAID) during the last month prior to inclusion (apart from low-dose acetylsalicylic acid)
- Consumption of more than 9 standard glasses of alcohol-containing drinks per week and/or more than 4 standard glasses per occasion
- Regular use of probiotic or prebiotic supplementation in the month prior to inclusion
- Any condition or intake of medication which could substantially interfere with the outcome of the study, as decided by the principal investigator's discretion
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo - no active ingredients
No active ingredients
|
Placebo product containing the same ingredients as the active intervention but without the active compounds
|
|
Experimental: Probiotic product
Product contains two probiotic strains
|
Product contains two probiotic strains
|
|
Experimental: Probiotic product plus fibre
Product contains two probiotic strains and a fibre (beta-glucan)
|
Product contains two probiotic strains plus a fibre (beta-glucan)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effect of a 6-week intake of a probiotic product on blood urate levels in hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected blood urate levels in the probiotic intervention arm after six weeks will be compared to the levels in the placebo arm
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effect of a 3-week intake of a probiotic product on blood urate levels in hyperuricaemic individuals compared to placebo
Time Frame: 3 weeks
|
Baseline-corrected blood urate levels in the probiotic intervention arm after three weeks will be compared to the levels in the placebo arm
|
3 weeks
|
|
Effect of a 3-week intake of a probiotic product in combination with a fibre on blood urate levels in hyperuricaemic individuals compared to placebo
Time Frame: 3 weeks
|
Baseline-corrected blood urate levels in the probiotic plus fibre intervention arm after three weeks will be compared to the levels in the placebo arm
|
3 weeks
|
|
Effect of a 6-week intake of a probiotic product in combination with a fibre on blood urate levels in hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected blood urate levels in the probiotic plus fibre intervention arm after six weeks will be compared to the levels in the placebo arm
|
6 weeks
|
|
Effect of a 3-week intake of a probiotic product on blood urate-related metabolites in hyperuricaemic individuals compared to placebo
Time Frame: 3 weeks
|
Baseline-corrected blood urate-related metabolite levels in the probiotic arm after three weeks will be compared to the levels in the placebo arm
|
3 weeks
|
|
Effect of a 6-week intake of a probiotic product on blood urate-related metabolites in hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected blood urate-related metabolite levels in the probiotic arm after six weeks will be compared to the levels in the placebo arm
|
6 weeks
|
|
Effect of a 3-week intake of a probiotic product in combination with a fibre on blood urate-related metabolites in hyperuricaemic individuals compared to placebo
Time Frame: 3 weeks
|
Baseline-corrected blood urate-related metabolite levels in the probiotic plus fibre arm after three weeks will be compared to the levels in the placebo arm
|
3 weeks
|
|
Effect of a 6-week intake of a probiotic product in combination with a fibre on blood urate-related metabolites in hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected blood urate-related metabolite levels in the probiotic plus fibre arm after six weeks will be compared to the levels in the placebo arm
|
6 weeks
|
|
Effect of a 3-week intake of a probiotic product on blood urate-related enzymes in hyperuricaemic individuals compared to placebo
Time Frame: 3 weeks
|
Baseline-corrected blood urate-related enzyme levels in the probiotic arm after three weeks will be compared to the levels in the placebo arm
|
3 weeks
|
|
Effect of a 6-week intake of a probiotic product on blood urate-related enzymes in hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected blood urate-related enzyme levels in the probiotic arm after six weeks will be compared to the levels in the placebo arm
|
6 weeks
|
|
Effect of a 3-week intake of a probiotic product in combination with a fibre on blood urate-related enzymes in hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected blood urate-related enzyme levels in the probiotic plus fibre arm after three weeks will be compared to the levels in the placebo arm
|
6 weeks
|
|
Effect of a 6-week intake of a probiotic product in combination with a fibre on blood urate-related enzymes in hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected blood urate-related enzyme levels in the probiotic plus fibre arm after six weeks will be compared to the levels in the placebo arm
|
6 weeks
|
|
Effect of a 3-week intake of a probiotic product on urate-related metabolites in stool of hyperuricaemic individuals compared to placebo
Time Frame: 3 weeks
|
Baseline-corrected urate-related metabolite levels in stool samples in the probiotic arm after three weeks will be compared to the levels in the placebo arm
|
3 weeks
|
|
Effect of a 6-week intake of a probiotic product on urate-related metabolites in stool of hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected urate-related metabolite levels in stool samples in the probiotic arm after six weeks will be compared to the levels in the placebo arm
|
6 weeks
|
|
Effect of a 3-week intake of a probiotic product in combination with a fibre on urate-related metabolites in stool of hyperuricaemic individuals compared to placebo
Time Frame: 3 weeks
|
Baseline-corrected urate-related metabolite levels in stool samples in the probiotic plus fibre arm after three weeks will be compared to the levels in the placebo arm
|
3 weeks
|
|
Effect of a 6-week intake of a probiotic product in combination with a fibre on urate-related metabolites in stool of hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected urate-related metabolite levels in stool samples in the probiotic plus fibre arm after six weeks will be compared to the levels in the placebo arm
|
6 weeks
|
|
Effect of a 3-week intake of a probiotic product on urate-related enzymes in stool of hyperuricaemic individuals compared to placebo
Time Frame: 3 weeks
|
Baseline-corrected urate-related enzyme levels in stool samples in the probiotic arm after three weeks will be compared to the levels in the placebo arm
|
3 weeks
|
|
Effect of a 6-week intake of a probiotic product on urate-related enzymes in stool of hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected urate-related enzymes levels in stool samples in the probiotic arm after six weeks will be compared to the levels in the placebo arm
|
6 weeks
|
|
Effect of a 3-week intake of a probiotic product in combination with a fibre on urate-related enzymes in stool of hyperuricaemic individuals compared to placebo
Time Frame: 3 weeks
|
Baseline-corrected urate-related enzyme levels in stool samples in the probiotic plus fibre arm after three weeks will be compared to the levels in the placebo arm
|
3 weeks
|
|
Effect of a 6-week intake of a probiotic product in combination with a fibre on urate-related enzymes in stool of hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected urate-related enzyme levels in stool samples in the probiotic plus fibre arm after six weeks will be compared to the levels in the placebo arm
|
6 weeks
|
|
Effect of a 3-week intake of a probiotic product on urate-related enzymes in urine of hyperuricaemic individuals compared to placebo
Time Frame: 3 weeks
|
Baseline-corrected urate-related enzymes levels in urine samples in the probiotic arm after three weeks will be compared to the levels in the placebo arm
|
3 weeks
|
|
Effect of a 6-week intake of a probiotic product on urate-related enzymes in urine of hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected urate-related enzymes levels in urine samples in the probiotic arm after six weeks will be compared to the levels in the placebo arm
|
6 weeks
|
|
Effect of a 3-week intake of a probiotic product in combination with a fibre on urate-related enzymes in urine of hyperuricaemic individuals compared to placebo
Time Frame: 3 weeks
|
Baseline-corrected urate-related enzymes levels in urine samples in the probiotic plus fibre arm after three weeks will be compared to the levels in the placebo arm
|
3 weeks
|
|
Effect of a 6-week intake of a probiotic product in combination with a fibre on urate-related enzymes in urine of hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected urate-related enzymes levels in urine samples in the probiotic plus fibre arm after six weeks will be compared to the levels in the placebo arm
|
6 weeks
|
|
Effect of a 3-week intake of a probiotic product on inflammation markers in blood of hyperuricaemic individuals compared to placebo
Time Frame: 3 weeks
|
Baseline-corrected inflammation markers in blood samples in the probiotic arm after three weeks will be compared to the levels in the placebo arm
|
3 weeks
|
|
Effect of a 6-week intake of a probiotic product on inflammation markers in blood of hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected inflammation markers in blood samples in the probiotic arm after six weeks will be compared to the levels in the placebo arm
|
6 weeks
|
|
Effect of a 3-week intake of a probiotic product in combination with a fibre on inflammation markers in blood of hyperuricaemic individuals compared to placebo
Time Frame: 3 weeks
|
Baseline-corrected inflammation markers in blood samples in the probiotic plus fibre arm after three weeks will be compared to the levels in the placebo arm
|
3 weeks
|
|
Effect of a 6-week intake of a probiotic product in combination with a fibre on inflammation markers in blood of hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected inflammation markers in blood samples in the probiotic plus fibre arm after six weeks will be compared to the levels in the placebo arm
|
6 weeks
|
|
Effect of a 3-week intake of a probiotic product on inflammation markers in stool of hyperuricaemic individuals compared to placebo
Time Frame: 3 weeks
|
Baseline-corrected inflammation markers in stool samples in the probiotic arm after three weeks will be compared to the levels in the placebo arm
|
3 weeks
|
|
Effect of a 6-week intake of a probiotic product on inflammation markers in stool of hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected inflammation markers in stool samples in the probiotic arm after six weeks will be compared to the levels in the placebo arm
|
6 weeks
|
|
Effect of a 3-week intake of a probiotic product in combination with a fibre on inflammation markers in stool of hyperuricaemic individuals compared to placebo
Time Frame: 3 weeks
|
Baseline-corrected inflammation markers in stool samples in the probiotic plus fibre arm after three weeks will be compared to the levels in the placebo arm
|
3 weeks
|
|
Effect of a 6-week intake of a probiotic product in combination with a fibre on inflammation markers in stool of hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected inflammation markers in stool samples in the probiotic plus fibre arm after six weeks will be compared to the levels in the placebo arm
|
6 weeks
|
|
Effect of a 3-week intake of a probiotic product on blood creatinine levels of hyperuricaemic individuals compared to placebo
Time Frame: 3 weeks
|
Baseline-corrected blood creatinine levels (eGFR - estimated glomerular filtration rate) in the probiotic arm after three weeks will be compared to the levels in the placebo arm
|
3 weeks
|
|
Effect of a 6-week intake of a probiotic product on blood creatinine levels of hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected blood creatinine levels (eGFR - estimated glomerular filtration rate) in the probiotic arm after six weeks will be compared to the levels in the placebo arm
|
6 weeks
|
|
Effect of a 3-week intake of a probiotic product in combination with a fibre on blood creatinine levels of hyperuricaemic individuals compared to placebo
Time Frame: 3 weeks
|
Baseline-corrected blood creatinine levels (eGFR - estimated glomerular filtration rate) in the probiotic plus fibre arm after three weeks will be compared to the levels in the placebo arm
|
3 weeks
|
|
Effect of a 6-week intake of a probiotic product in combination with a fibre on blood creatinine levels of hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected blood creatinine levels (eGFR - estimated glomerular filtration rate) in the probiotic plus fibre arm after six weeks will be compared to the levels in the placebo arm
|
6 weeks
|
|
Effect of a 3-week intake of a probiotic product on urine creatinine levels of hyperuricaemic individuals compared to placebo
Time Frame: 3 weeks
|
Baseline-corrected urine creatinine levels in the probiotic arm after three weeks will be compared to the levels in the placebo arm
|
3 weeks
|
|
Effect of a 6-week intake of a probiotic product on urine creatinine levels of hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected urine creatinine levels in the probiotic arm after six weeks will be compared to the levels in the placebo arm
|
6 weeks
|
|
Effect of a 3-week intake of a probiotic product in combination with a fibre on urine creatinine levels of hyperuricaemic individuals compared to placebo
Time Frame: 3 weeks
|
Baseline-corrected urine creatinine levels in the probiotic plus fibre arm after three weeks will be compared to the levels in the placebo arm
|
3 weeks
|
|
Effect of a 6-week intake of a probiotic product in combination with a fibre on urine creatinine levels of hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected urine creatinine levels in the probiotic plus fibre arm after six weeks will be compared to the levels in the placebo arm
|
6 weeks
|
|
Effect of a 3-week intake of a probiotic product on urate levels in stool of hyperuricaemic individuals compared to placebo
Time Frame: 3 weeks
|
Baseline-corrected urate levels in stool samples of the probiotic intervention arm after three weeks will be compared to the levels in the placebo arm
|
3 weeks
|
|
Effect of a 6-week intake of a probiotic product on urate levels in stool of hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected urate levels in stool samples of the probiotic intervention arm after six weeks will be compared to the levels in the placebo arm
|
6 weeks
|
|
Effect of a 3-week intake of a probiotic product in combination with a fibre on urate levels in stool of hyperuricaemic individuals compared to placebo
Time Frame: 3 weeks
|
Baseline-corrected urate levels in stool samples of the probiotic plus fibre intervention arm after three weeks will be compared to the levels in the placebo arm
|
3 weeks
|
|
Effect of a 6-week intake of a probiotic product in combination with a fibre on urate levels in stool of hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected urate levels in stool samples of the probiotic plus fibre intervention arm after six weeks will be compared to the levels in the placebo arm
|
6 weeks
|
|
Effect of a 3-week intake of a probiotic product on urate levels in urine of hyperuricaemic individuals compared to placebo
Time Frame: 3 weeks
|
Baseline-corrected urate levels in urine samples of the probiotic intervention arm after three weeks will be compared to the levels in the placebo arm
|
3 weeks
|
|
Effect of a 6-week intake of a probiotic product on urate levels in urine of hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected urate levels in urine samples of the probiotic intervention arm after six weeks will be compared to the levels in the placebo arm
|
6 weeks
|
|
Effect of a 3-week intake of a probiotic product in combination with a fibre on urate levels in urine of hyperuricaemic individuals compared to placebo
Time Frame: 3 weeks
|
Baseline-corrected urate levels in urine samples of the probiotic plus fibre intervention arm after three weeks will be compared to the levels in the placebo arm
|
3 weeks
|
|
Effect of a 6-week intake of a probiotic product in combination with a fibre on urate levels in urine of hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected urate levels in urine samples of the probiotic plus fibre intervention arm after six weeks will be compared to the levels in the placebo arm
|
6 weeks
|
|
Effect of a 3-week intake of a probiotic product on urate-related metabolites in urine of hyperuricaemic individuals compared to placebo
Time Frame: 3 weeks
|
Baseline-corrected urate-related metabolite levels in urine samples in the probiotic arm after three weeks will be compared to the levels in the placebo arm
|
3 weeks
|
|
Effect of a 6-week intake of a probiotic product on urate-related metabolites in urine of hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected urate-related metabolite levels in urine samples in the probiotic arm after six weeks will be compared to the levels in the placebo arm
|
6 weeks
|
|
Effect of a 3-week intake of a probiotic product in combination with a fibre on urate-related metabolites in urine of hyperuricaemic individuals compared to placebo
Time Frame: 3 weeks
|
Baseline-corrected urate-related metabolite levels in urine samples in the probiotic plus fibre arm after three weeks will be compared to the levels in the placebo arm
|
3 weeks
|
|
Effect of a 6-week intake of a probiotic product in combination with a fibre on urate-related metabolites in urine of hyperuricaemic individuals compared to placebo
Time Frame: 6 weeks
|
Baseline-corrected urate-related metabolite levels in urine samples in the probiotic plus fibre arm after six weeks will be compared to the levels in the placebo arm
|
6 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2025-04358-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hyperuricemia With or Without Gout
-
Guangdong Hengqin Novagains Biopharmaceutical Co...Xiangbei Welman Pharmaceutical Co., Ltd; Guangzhou Xin-Chuangyi Biopharmaceutical...Not yet recruitingHyperuricemia With or Without GoutChina
-
Guangdong Hengqin Novagains Biopharmaceutical Co...Xiangbei Welman Pharmaceutical Co., Ltd; Guangzhou Xin-Chuangyi Biopharmaceutical...Enrolling by invitationHyperuricemia With or Without GoutChina
-
Beijing Zhecheng Biotechnology Co., Ltd.Not yet recruitingHyperuricemia With or Without GoutChina
-
Fuji Yakuhin Co., Ltd.Mochida Pharmaceutical Company, Ltd.Completed
-
Mochida Pharmaceutical Company, Ltd.Fuji Yakuhin Co., Ltd.CompletedHyperuricemia With or Without GoutJapan
-
Fuji Yakuhin Co., Ltd.Mochida Pharmaceutical Company, Ltd.CompletedHyperuricemia With or Without GoutJapan
-
Mochida Pharmaceutical Company, Ltd.Fuji Yakuhin Co., Ltd.CompletedHyperuricemia With or Without GoutJapan
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingPrimary Gout With Hyperuricemia in Adults
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingPrimary Gout and HyperuricemiaChina
-
OMNIFARMA LLCRecruitingHyperuricemia or GoutUkraine
Clinical Trials on Placebo (no active ingredient)
-
University of Notre DameJohns Hopkins University; Ministry of Health, Zambia; Macha Research Trust, ZambiaWithdrawn
-
Lund UniversityVinnova; Antidiabetic Food Centre AFCCompleted
-
University of Notre DameIndonesia-MoHCompleted
-
University of Notre DameIfakara Health InstituteWithdrawn
-
University of Notre DameCenters for Disease Control and Prevention; Kenya Medical Research InstituteWithdrawn
-
Anbiome Labs LLCSarajevo School of Science and Technology, Medical School Department; Public...CompletedDry Skin; Eczema | Overall Skin AppearanceBosnia and Herzegovina
-
Olly, PBCCompleted
-
HaEmek Medical Center, IsraelTerminatedFunctional ConstipationIsrael
-
Clinical Research Centre, MalaysiaAin Medicare Sdn BhdRecruiting